Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bronchospasmin
2. Epiferol
3. Reproterol
4. Reproterol Monohydrochloride
5. Reproterol, (-)-isomer
1. Bronchodil
2. Bronchospasmin
3. 13055-82-8
4. Asmaterolo
5. Reproterol Hydrochloride [usan]
6. W-2946m
7. D-1959.hcl
8. Y4i1coj8w8
9. 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione Monohydrochloride
10. 13055-82-8 (hcl)
11. 1h-purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-, Monohydrochloride
12. Reproterol Hydrochloride (usan)
13. Reproterol Hcl
14. 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione Hydrochloride
15. 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione Monohydrochloride
16. 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-1,3-dimethylpurine-2,6-dione;hydrochloride
17. D 1959 Hcl
18. Einecs 235-942-3
19. Unii-y4i1coj8w8
20. Einecs 254-666-4
21. Reproterolhydrochlorid
22. D 1959 (-)
23. 7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)theophylline Monohydrochloride
24. 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxy-ethyl)amino)propyl)theophylline Hydrochloride
25. 1h-purine-2,6-dione, 3,7-dihydro-7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-1,3-dimethyl-, Monohydrochloride, (-)-
26. 39878-37-0
27. Schembl637198
28. D-1959 Hydrochloride
29. Chembl2104771
30. Dtxsid60926797
31. Reproterol Hydrochloride [mi]
32. Akos022180842
33. Reproterol Hydrochloride [mart.]
34. Theophylline, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-, Hydrochloride
35. Reproterol Hydrochloride [who-dd]
36. 62932-28-9
37. 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione Hydrochloride
38. D05718
39. Q27294256
40. 7-(3-((.beta.,3,5-trihydroxyphenethyl)amino)propyl)theophylline Monohydrochloride
41. Theophylline, 7-(3-((.beta.,3,5-trihydroxyphenethyl)amino)propyl)-, Hydrochloride
42. 1h-purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-, Hydrochloride (1:1)
43. 7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1h-purine-2,6-dione--hydrogen Chloride (1/1)
44. 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-3,7-dihydro-1,3-dimethyl-1h-purine-2,6-d
| Molecular Weight | 425.9 g/mol |
|---|---|
| Molecular Formula | C18H24ClN5O5 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 425.1465966 g/mol |
| Monoisotopic Mass | 425.1465966 g/mol |
| Topological Polar Surface Area | 131 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 569 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adrenergic beta-Agonists
Drugs that selectively bind to and activate beta-adrenergic receptors. (See all compounds classified as Adrenergic beta-Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
ABOUT THIS PAGE
A Bronchodil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bronchodil, including repackagers and relabelers. The FDA regulates Bronchodil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bronchodil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bronchodil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bronchodil supplier is an individual or a company that provides Bronchodil active pharmaceutical ingredient (API) or Bronchodil finished formulations upon request. The Bronchodil suppliers may include Bronchodil API manufacturers, exporters, distributors and traders.
click here to find a list of Bronchodil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Bronchodil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bronchodil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bronchodil GMP manufacturer or Bronchodil GMP API supplier for your needs.
A Bronchodil CoA (Certificate of Analysis) is a formal document that attests to Bronchodil's compliance with Bronchodil specifications and serves as a tool for batch-level quality control.
Bronchodil CoA mostly includes findings from lab analyses of a specific batch. For each Bronchodil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bronchodil may be tested according to a variety of international standards, such as European Pharmacopoeia (Bronchodil EP), Bronchodil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bronchodil USP).
LOOKING FOR A SUPPLIER?
